M. Kağıtcı Et Al. , "Does STAT-3 and IL-26 activity have a place in the pathophysiology of endometrioma?," 2025, V2
Kağıtcı, M. Et Al. 2025. Does STAT-3 and IL-26 activity have a place in the pathophysiology of endometrioma?. , V2
Kağıtcı, M., Şentürk, Ş., Mercantepe, T., Dereci Delibaş, D., & Bedir, R., (2025). Does STAT-3 and IL-26 activity have a place in the pathophysiology of endometrioma?. , V2
Kağıtcı, MEHMET Et Al. "Does STAT-3 and IL-26 activity have a place in the pathophysiology of endometrioma?," , V2, 2025
Kağıtcı, MEHMET Et Al. "Does STAT-3 and IL-26 activity have a place in the pathophysiology of endometrioma?." 2025, V2
Kağıtcı, M. Et Al. (2025) . "Does STAT-3 and IL-26 activity have a place in the pathophysiology of endometrioma?." , V2.
@misc{ url={https://avesis.erdogan.edu.tr/ScientificDataShare/Details/098856d4-3ae6-4e33-828d-591d69eb82da/does-stat-3-and-ıl-26-activity-have-a-place-in-the-pathophysiology-of-endometrioma??isLastVersion=false}, author={MEHMET KAĞITCI Et Al. }, title={Does STAT-3 and IL-26 activity have a place in the pathophysiology of endometrioma?}, publisher={ Recep Tayyip Erdoğan Üniversitesi AVESİS Veri }, year={2025}}